XML 107 R56.htm IDEA: XBRL DOCUMENT v3.6.0.2
Investments (Schedule Of Fair Value Method Investments, Balance Sheets And Income Statements) (Details) - USD ($)
 3 Months Ended 12 Months Ended
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Assets                        
Cash and cash equivalents $ 29,511,000 [1]       $ 44,156,000 [1]       $ 29,511,000 [1] $ 44,156,000 [1] $ 50,056,000 $ 52,617,000
Net property, plant and equipment 260,725,000       231,315,000       260,725,000 231,315,000    
Other assets and deferred charges 30,790,000       27,869,000       30,790,000 27,869,000    
Total assets [1] 651,162,000       623,260,000       651,162,000 623,260,000    
Liabilities and Shareholders’ Equity                        
Other noncurrent liabilities 95,000,000       104,000,000       95,000,000 104,000,000    
Equity 310,783,000       272,748,000       310,783,000 272,748,000 372,029,000 $ 402,664,000
Total liabilities and shareholders’ equity 651,162,000       623,260,000       651,162,000 623,260,000    
Revenues & Expenses:                        
Cost of goods sold                 668,626,000 725,459,000 778,113,000  
Income tax (expense) benefit [2]                 (3,217,000) (8,928,000) (9,387,000)  
Net income (loss) 1,728,000 $ 12,048,000 $ 3,408,000 $ 7,281,000 (5,876,000) $ (36,723,000) $ 594,000 $ 9,870,000 24,466,000 (32,135,000) 36,879,000  
kaleo                        
Assets                        
Cash and cash equivalents 102,329,000       91,844,000       102,329,000 91,844,000    
Restricted cash 31,000       8,182,000       31,000 8,182,000    
Other current assets 15,391,000       9,070,000       15,391,000 9,070,000    
Net property, plant and equipment 13,011,000       8,453,000       13,011,000 8,453,000    
Other assets and deferred charges 472,000       2,903,000       472,000 2,903,000    
Total assets 131,234,000       120,452,000       131,234,000 120,452,000    
Liabilities and Shareholders’ Equity                        
Current liabilities 50,134,000       10,261,000       50,134,000 10,261,000    
Liabilities, Other than Long-term Debt, Noncurrent 822,000       552,000       822,000 552,000    
Other noncurrent liabilities 143,380,000       142,696,000       143,380,000 142,696,000    
Equity (63,102,000)       (33,057,000)       (63,102,000) (33,057,000)    
Total liabilities and shareholders’ equity $ 131,234,000       $ 120,452,000       131,234,000 120,452,000    
Revenues & Expenses:                        
Revenues                 56,188,000 35,731,000 21,156,000  
Cost of goods sold                 15,428,000 14,147,000 3,801,000  
Expenses and other, net                 71,548,000 63,042,000 48,447,000  
Income tax (expense) benefit                 (35,000) (481,000) 8,100,000  
Net income (loss)                 (30,823,000) (41,939,000) (22,992,000)  
Effect of Excluding Gain on Contract Termination from Expenses and Other, Net                 89.6      
Harbinger Capital Partners Special Situations Fund L P [Member]                        
Investments, Other Investments [Line Items]                        
Total Withdrawal Proceeds Received                 $ 0 $ 100,000 $ 200,000  
[1] Information on exports and foreign operations are provided on the previous page. Cash and cash equivalents includes funds held in locations outside the U.S. of $23.8 million and $27.7 million at December 31, 2016 and 2015, respectively. Export sales relate almost entirely to PE Films. Operations outside the U.S. in The Netherlands, Hungary, China and India also relate to PE Films. Operations in Brazil are primarily related to Flexible Packaging Films, but also include PE Films operations. Sales from locations in The Netherlands and Hungary are primarily to customers located in Europe. Sales from locations in China (Guangzhou and Shanghai) are primarily to customers located in China, but also include other customers in Asia.
[2] See Notes 1, 3, 4 and 18 for more information on losses associated with plant shutdowns, asset impairments and restructurings, unusual items, gains or losses from sale of assets, gains or losses on an investment accounted for under the fair value method and other items.